178 related articles for article (PubMed ID: 28355345)
1. Chronic dosing with mirtazapine does not produce sedation in rats.
Salazar-Juárez A; Barbosa-Méndez S; Merino-Reyes P; Matus-Ortega M; Hernández-Calderón JA; Antón B
Braz J Psychiatry; 2017; 39(3):228-236. PubMed ID: 28355345
[TBL] [Abstract][Full Text] [Related]
2. Effects of repeated dosing with mirtazapine, trazodone, or placebo on driving performance and cognitive function in healthy volunteers.
Sasada K; Iwamoto K; Kawano N; Kohmura K; Yamamoto M; Aleksic B; Ebe K; Noda Y; Ozaki N
Hum Psychopharmacol; 2013 May; 28(3):281-6. PubMed ID: 23661283
[TBL] [Abstract][Full Text] [Related]
3. Repeated treatment with mirtazepine induces brain-derived neurotrophic factor gene expression in rats.
Rogóz Z; Skuza G; Legutko B
J Physiol Pharmacol; 2005 Dec; 56(4):661-71. PubMed ID: 16391422
[TBL] [Abstract][Full Text] [Related]
4. Mirtazapine, an antidepressant.
Puzantian T
Am J Health Syst Pharm; 1998 Jan; 55(1):44-9. PubMed ID: 9437474
[TBL] [Abstract][Full Text] [Related]
5. Dose- and time-dependent effects of mirtazapine on the expression of cocaine-induced behavioral sensitization in rats.
Barbosa-Méndez S; Matus-Ortega M; Flores-Zamora A; Jurado N; Salazar-Juárez A
Psychiatry Res; 2017 Aug; 254():301-310. PubMed ID: 28501735
[TBL] [Abstract][Full Text] [Related]
6. Tachyphylaxis to the Sedative Action of Mirtazapine.
Papazisis G; Siafis S; Tzachanis D
Am J Case Rep; 2018 Apr; 19():410-412. PubMed ID: 29626184
[TBL] [Abstract][Full Text] [Related]
7. [Mirtazapine--an antidepressant].
Landowski J
Psychiatr Pol; 2002; 36(6 Suppl):125-30. PubMed ID: 12647431
[TBL] [Abstract][Full Text] [Related]
8. Influence of mirtazapine on the hypotensive activity of enalapril and propranolol in spontaneously hypertensive rats.
Andrzejczak D; Kocon K; Zieba R
Basic Clin Pharmacol Toxicol; 2008 Nov; 103(5):450-4. PubMed ID: 18699796
[TBL] [Abstract][Full Text] [Related]
9. Mirtazapine, a noradrenergic and specific serotonergic antidepressant, attenuates morphine dependence and withdrawal in Sprague-Dawley rats.
Kang L; Wang D; Li B; Hu M; Zhang P; Li J
Am J Drug Alcohol Abuse; 2008; 34(5):541-52. PubMed ID: 18618337
[TBL] [Abstract][Full Text] [Related]
10. The effect of risperidone on the mirtazapine-induced changes in extracellular monoamines in the rat frontal cortex.
Kamińska K; Gołembiowska K; Rogóż Z
Pharmacol Rep; 2014 Dec; 66(6):984-90. PubMed ID: 25443725
[TBL] [Abstract][Full Text] [Related]
11. Mirtazapine: a newer antidepressant.
Hartmann PM
Am Fam Physician; 1999 Jan; 59(1):159-61. PubMed ID: 9917581
[TBL] [Abstract][Full Text] [Related]
12. A risk-benefit assessment of mirtazapine in the treatment of depression.
Kasper S; Praschak-Rieder N; Tauscher J; Wolf R
Drug Saf; 1997 Oct; 17(4):251-64. PubMed ID: 9352961
[TBL] [Abstract][Full Text] [Related]
13. Melatonin does not produce sedation in rats: A chronobiological study.
Barbosa-Méndez S; Salazar-Juarez A
Chronobiol Int; 2020 Mar; 37(3):353-374. PubMed ID: 31851848
[No Abstract] [Full Text] [Related]
14. Safety of mirtazapine: a review.
Montgomery SA
Int Clin Psychopharmacol; 1995 Dec; 10 Suppl 4():37-45. PubMed ID: 8930008
[TBL] [Abstract][Full Text] [Related]
15. Suppressive effect of mirtazapine on the HPA system in acutely depressed women seems to be transient and not related to antidepressant action.
Horstmann S; Dose T; Lucae S; Kloiber S; Menke A; Hennings J; Spieler D; Uhr M; Holsboer F; Ising M
Psychoneuroendocrinology; 2009 Feb; 34(2):238-248. PubMed ID: 18926641
[TBL] [Abstract][Full Text] [Related]
16. Behavioral and memory improving effects of mirtazapine in rats.
Nowakowska E; Chodera A; Kus K
Pol J Pharmacol; 1999; 51(6):463-9. PubMed ID: 10817523
[TBL] [Abstract][Full Text] [Related]
17. Efficacy, tolerability, and preference of mirtazapine orally disintegrating tablets in depressed patients: a 17-week naturalistic study in Lithuania.
Danileviciūte V; Sveikata A; Adomaitiene V; Gumbrevicius G; Fokas V; Sveikatiene R
Medicina (Kaunas); 2009; 45(10):778-84. PubMed ID: 19996664
[TBL] [Abstract][Full Text] [Related]
18. Biochemical and histologic study of lethal cisplatin nephrotoxicity prevention by mirtazapine.
Sener MT; Sener E; Tok A; Polat B; Cinar I; Polat H; Akcay F; Suleyman H
Pharmacol Rep; 2012; 64(3):594-602. PubMed ID: 22814013
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of mirtazapine in treating major depressive disorder with anxiety symptoms: an 8-week open-label randomised paroxetine-controlled trial.
Kim JE; Yoon SJ; Kim J; Jung JY; Jeong HS; Cho HB; Shin E; Lyoo IK; Kim TS
Int J Clin Pract; 2011 Mar; 65(3):323-9. PubMed ID: 21314870
[TBL] [Abstract][Full Text] [Related]
20. Mirtazapine monotherapy versus combination therapy with mirtazapine and aripiprazole in depressed patients without psychotic features: a 4-week open-label parallel-group study.
Schüle C; Baghai TC; Eser D; Hecht S; Hermisson I; Born C; Häfner S; Nothdurfter C; Rupprecht R
World J Biol Psychiatry; 2007; 8(2):112-22. PubMed ID: 17455104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
